Nelson is a recognized European investor and entrepreneur-in-residence supporting projects across healthcare, sustainability and fin-tech. He serves as the US director of Abionic, a leading Swiss Scale-up which developed the world's fastest Point of Care diagnostics platform. The device's flagship test enables the earliest detection of Sepsis, potentially saving millions of lives if deployed at scale.